Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Introduction: Fetal heart rate (FHR) monitoring is one of the commonest and most affordable tests performed during pregnancy worldwide. It is critical for evaluating the health status of the baby, providing real-time insights into the physiology of the fetus. While the relationship between patterns in these signals and adverse pregnancy outcomes is well-established, human identification of these complex patterns remains sub-optimal, with experts often failing to recognise babies at high-risk of outcomes such as asphyxia, growth restriction and stillbirth. These outcomes are especially relevant in low- and middle-income countries where an estimated 98% of perinatal deaths occur. Pre-term birth complications are also the leading cause of death in children <5 years of age, 75% of which can be prevented. While advances have been made in developing low-cost digital solutions for antenatal fetal monitoring, there is still substantial progress to be made in developing tools for the identification of high-risk, adverse outcome pre-term pregnancies using these FHR systems. In this study, we have developed the first machine learning algorithm for the identification of high-risk preterm pregnancies with associated adverse outcomes using fetal heart rate monitoring. Methods: We sourced antepartum fetal heart rate traces from high-risk, pre-term pregnancies that were assigned at least one of ten adverse conditions. These were matched with normal pregnancies delivered at term. Using an automated, clinically-validated algorithm, seven distinct fetal heart rate patterns were extracted from each trace, subsequently filtered for outliers and normalized. The data were split into 80% for model development and 20% for validation. Six machine learning algorithms were trained using k-fold cross-validation to identify each trace as either normal or high-risk preterm. The best-performing algorithm was further evaluated using the validation dataset based on metrics including the AUC, sensitivity, and specificity at three distinct classification thresholds. Additional assessments included decision curve analysis and gestational age-specific and outcome-specific performance evaluations. Results: We analysed antepartum fetal heart rate recordings from 4,867 high-risk, pre-term pregnancies with adverse outcomes and 4,014 normal pregnancies. Feature extraction and preprocessing revealed significant differences between the groups (p<0.001). The random forest classifier was the most effective model, achieving an AUC of 0.88 (95% CI 0.87-0.88). When evaluating specific adverse outcomes, the median AUC was 0.85 (IQR 0.81-0.89) and the model consistently exceeded an AUC of 0.80 across all gestational ages. The model's robustness was confirmed on the validation dataset with an AUC of 0.88 (95% CI 0.86-0.90) and a Brier score of 0.14. Decision curve analysis showed the model surpassed both the treat-none and treat-all strategies over most probability thresholds (0.11-1.0). Performance metrics when using the Youden index were as follows: sensitivity 76.2% (95% CI 72.6-80.5%), specificity 87.5% (95% CI 83.3-91.0), F1 score 81.7 (95% CI 79.6-83.9), and Cohen's kappa 62.8 (95% CI 59.6-66.4), indicating high discriminative ability between pregnancy outcomes. Conclusions: Our study successfully demonstrated machine learning algorithms are capable of identifying high-risk preterm pregnancies with associated adverse outcomes through fetal heart rate monitoring. These findings demonstrate the potential of machine learning in enhancing the accuracy and effectiveness of antenatal fetal monitoring, particularly for high-risk cases where timely intervention is crucial. This algorithm could substantially improve pregnancy outcome prediction and consequently, maternal and neonatal care, especially in low- to middle-income countries where the burden of adverse outcomes is high.
Introduction: Fetal heart rate (FHR) monitoring is one of the commonest and most affordable tests performed during pregnancy worldwide. It is critical for evaluating the health status of the baby, providing real-time insights into the physiology of the fetus. While the relationship between patterns in these signals and adverse pregnancy outcomes is well-established, human identification of these complex patterns remains sub-optimal, with experts often failing to recognise babies at high-risk of outcomes such as asphyxia, growth restriction and stillbirth. These outcomes are especially relevant in low- and middle-income countries where an estimated 98% of perinatal deaths occur. Pre-term birth complications are also the leading cause of death in children <5 years of age, 75% of which can be prevented. While advances have been made in developing low-cost digital solutions for antenatal fetal monitoring, there is still substantial progress to be made in developing tools for the identification of high-risk, adverse outcome pre-term pregnancies using these FHR systems. In this study, we have developed the first machine learning algorithm for the identification of high-risk preterm pregnancies with associated adverse outcomes using fetal heart rate monitoring. Methods: We sourced antepartum fetal heart rate traces from high-risk, pre-term pregnancies that were assigned at least one of ten adverse conditions. These were matched with normal pregnancies delivered at term. Using an automated, clinically-validated algorithm, seven distinct fetal heart rate patterns were extracted from each trace, subsequently filtered for outliers and normalized. The data were split into 80% for model development and 20% for validation. Six machine learning algorithms were trained using k-fold cross-validation to identify each trace as either normal or high-risk preterm. The best-performing algorithm was further evaluated using the validation dataset based on metrics including the AUC, sensitivity, and specificity at three distinct classification thresholds. Additional assessments included decision curve analysis and gestational age-specific and outcome-specific performance evaluations. Results: We analysed antepartum fetal heart rate recordings from 4,867 high-risk, pre-term pregnancies with adverse outcomes and 4,014 normal pregnancies. Feature extraction and preprocessing revealed significant differences between the groups (p<0.001). The random forest classifier was the most effective model, achieving an AUC of 0.88 (95% CI 0.87-0.88). When evaluating specific adverse outcomes, the median AUC was 0.85 (IQR 0.81-0.89) and the model consistently exceeded an AUC of 0.80 across all gestational ages. The model's robustness was confirmed on the validation dataset with an AUC of 0.88 (95% CI 0.86-0.90) and a Brier score of 0.14. Decision curve analysis showed the model surpassed both the treat-none and treat-all strategies over most probability thresholds (0.11-1.0). Performance metrics when using the Youden index were as follows: sensitivity 76.2% (95% CI 72.6-80.5%), specificity 87.5% (95% CI 83.3-91.0), F1 score 81.7 (95% CI 79.6-83.9), and Cohen's kappa 62.8 (95% CI 59.6-66.4), indicating high discriminative ability between pregnancy outcomes. Conclusions: Our study successfully demonstrated machine learning algorithms are capable of identifying high-risk preterm pregnancies with associated adverse outcomes through fetal heart rate monitoring. These findings demonstrate the potential of machine learning in enhancing the accuracy and effectiveness of antenatal fetal monitoring, particularly for high-risk cases where timely intervention is crucial. This algorithm could substantially improve pregnancy outcome prediction and consequently, maternal and neonatal care, especially in low- to middle-income countries where the burden of adverse outcomes is high.
Introduction: Antepartum fetal heart rate (FHR) patterns are routinely assessed using to evaluate fetal well-being. Despite their clinical use, the relationship between specific FHR patterns and adverse pregnancy outcomes (APOs) remains unclear. This study aims to investigate the association between antepartum FHR patterns and APOs to improve fetal risk assessment. Methods: In this retrospective case-control study, we extracted raw antepartum FHR traces from singleton pregnancies between 27⁺⁰ and 41⁺⁶ weeks' gestation recorded at Oxford University Hospitals from January 1991 to February 2024. Adverse outcomes included acidaemia, stillbirth, asphyxia, extended neonatal care unit (NCU) admission, hypoxic-ischaemic encephalopathy (HIE), low Apgar scores and neonatal resuscitation at delivery. After applying inclusion and exclusion criteria, 938 FHR traces with APOs were matched using propensity score matching with 938 traces from normal pregnancy outcomes (NPOs), controlling for gestational age, fetal sex, maternal BMI, maternal age, parity, and trace duration. FHR patterns were extracted using a validated automated algorithm and analysed statistically. Results: The APO cohort showed significantly higher basal heart rates (BHR), fewer accelerations, more decelerations, lower short-term variability (STV), and spent a greater proportion of the trace in periods of low variation compared to the NPO cohort (p < 0.001). Logistic regression identified prolonged periods of low variation (odds ratio [OR] = 1.92, 95% CI 1.60-2.30), increased decelerations (OR = 1.40, 95% CI 1.22-1.60), reduced accelerations (OR = 0.66, 95% CI 0.55-0.78), elevated BHR (OR = 0.70, 95% CI 0.61-0.80), and decreased STV (OR = 0.72, 95% CI 0.57-0.91) as significant predictors of APOs. Conclusions: Specific antepartum FHR patterns are significantly associated with adverse pregnancy outcomes. Detailed analysis of these patterns can enhance fetal risk assessment and inform clinical decision-making. Adoption of standardised interpretation criteria for antepartum FHR monitoring may improve perinatal outcomes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.